These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Nonviral gene therapy: the promise of genes as pharmaceutical products. Ledley FD Hum Gene Ther; 1995 Sep; 6(9):1129-44. PubMed ID: 8527471 [TBL] [Abstract][Full Text] [Related]
3. Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature. Young JL; Benoit JN; Dean DA Gene Ther; 2003 Aug; 10(17):1465-70. PubMed ID: 12900761 [TBL] [Abstract][Full Text] [Related]
4. New serine-derived gemini surfactants as gene delivery systems. Cardoso AM; Morais CM; Cruz AR; Silva SG; do Vale ML; Marques EF; de Lima MC; Jurado AS Eur J Pharm Biopharm; 2015 Jan; 89():347-56. PubMed ID: 25513958 [TBL] [Abstract][Full Text] [Related]
6. Non-viral nanosystems for gene and small interfering RNA delivery to the central nervous system: formulating the solution. O'Mahony AM; Godinho BM; Cryan JF; O'Driscoll CM J Pharm Sci; 2013 Oct; 102(10):3469-84. PubMed ID: 23893329 [TBL] [Abstract][Full Text] [Related]
7. DNA nanoparticles and development of DNA delivery vehicles for gene therapy. Vijayanathan V; Thomas T; Thomas TJ Biochemistry; 2002 Dec; 41(48):14085-94. PubMed ID: 12450371 [TBL] [Abstract][Full Text] [Related]
8. A physicochemical approach for predicting the effectiveness of peptide-based gene delivery systems for use in plasmid-based gene therapy. Duguid JG; Li C; Shi M; Logan MJ; Alila H; Rolland A; Tomlinson E; Sparrow JT; Smith LC Biophys J; 1998 Jun; 74(6):2802-14. PubMed ID: 9635734 [TBL] [Abstract][Full Text] [Related]
9. Structured substrates and delivery vehicles: trending now in biomedicine. Pandit A; Zeugolis DI Nanomedicine (Lond); 2016 Jun; 11(12):1489-93. PubMed ID: 27353654 [No Abstract] [Full Text] [Related]
11. [Long circulation liposome and nuclear medicine]. Ma C; Kuang A Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2007 Aug; 24(4):941-5. PubMed ID: 17899779 [TBL] [Abstract][Full Text] [Related]
12. Gene medicines: the end of the beginning? Rolland A Adv Drug Deliv Rev; 2005 Apr; 57(5):669-73. PubMed ID: 15757753 [TBL] [Abstract][Full Text] [Related]
13. Bioplex technology: novel synthetic gene delivery pharmaceutical based on peptides anchored to nucleic acids. Simonson OE; Svahn MG; Törnquist E; Lundin KE; Smith CI Curr Pharm Des; 2005; 11(28):3671-80. PubMed ID: 16305503 [TBL] [Abstract][Full Text] [Related]
14. The search for drug target molecules from genomics. Masuho Y; Matsumoto S; Isogai T; Nagai K; Nagahari K BJU Int; 2001 Sep; 88 Suppl 2():11-7; discussion 49-50. PubMed ID: 11589664 [No Abstract] [Full Text] [Related]
15. Applications of DNA shuffling to pharmaceuticals and vaccines. Patten PA; Howard RJ; Stemmer WP Curr Opin Biotechnol; 1997 Dec; 8(6):724-33. PubMed ID: 9425664 [TBL] [Abstract][Full Text] [Related]
16. Potential new methods for antiepileptic drug delivery. Fisher RS; Ho J CNS Drugs; 2002; 16(9):579-93. PubMed ID: 12153331 [TBL] [Abstract][Full Text] [Related]
17. Self-nanoemulsifying drug delivery systems as novel approach for pDNA drug delivery. Hauptstein S; Prüfert F; Bernkop-Schnürch A Int J Pharm; 2015 Jun; 487(1-2):25-31. PubMed ID: 25839413 [TBL] [Abstract][Full Text] [Related]
18. Sphingosine-based liposome as DNA vector for intramuscular gene delivery. Baraldo K; Leforestier N; Bureau M; Mignet N; Scherman D Pharm Res; 2002 Aug; 19(8):1144-9. PubMed ID: 12240940 [TBL] [Abstract][Full Text] [Related]